Skip to content

IDEAYA Biosciences, Inc. IDYA Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Amgen logo
AmgenAMGN
$189.67B+13.3%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$2.99B+1,915%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$2.71B+226%
Erasca, Inc. logo
Erasca, Inc.ERAS
$5.03B+1,196%
Immunome logo
ImmunomeIMNM
$2.47B+323%

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Computed from the period-end share price: $2.93B.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s market capitalization?
IDEAYA Biosciences, Inc. (IDYA) reported market capitalization of $2.93B in Q1 2026.
How has IDEAYA Biosciences, Inc.'s market capitalization changed year-over-year?
IDEAYA Biosciences, Inc.'s market capitalization increased by 104.1% year-over-year, from $1.43B to $2.93B.
What is the long-term trend for IDEAYA Biosciences, Inc.'s market capitalization?
Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s market capitalization has grown at a 41.3% compound annual growth rate (CAGR), from $538.96M to $3.03B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.